Eletriptan HBR
Eletriptan HBR is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Eletriptan HBR; Generic name: ELETRIPTAN HBR; Manufacturer: Direct_Rx.
| Brand name | Eletriptan HBR |
|---|---|
| Generic name | ELETRIPTAN HBR |
| Manufacturer | Direct_Rx |
| Used for | Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with eletriptan hydrobromide tablets, reconsider the diagnosis of migraine before eletriptan hydrobromide tablets are administered to treat any subsequent attacks. Eletriptan hydrobromide tablets are not intended for the prevention of migraine attacks. Safety and effectiveness of eletriptan hydrobromide tablets have not been established for cluster headache. |
| Dosage | The maximum recommended single dose is 40 mg. In controlled clinical trials, single doses of 20 mg and 40 mg were effective for the acute treatment of migraine in adults. A greater proportion of patients had a response following a 40 mg dose than following a 20 mg dose [see CLINICAL STUDIES (14)]. If the migraine has not resolved by 2 hours after taking eletriptan hydrobromide tablets, or returns after transient improvement, a second dose may be administered at least 2 hours after the first dose |
| Active ingredient(s) | ELETRIPTAN HYDROBROMIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=077134d1-427d-6235-e063-6394a90abcf6 |